Atrás
Rango del Día
$3.27
$3.40
Rango de 52 Semanas
$1.15
$6.75
Volumen
4,976,975
Promedio 50D / 200D
$3.80
/
$4.04
Cierre Anterior
$3.39
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -1.0 | 0.3 |
| P/B | 2.9 | 2.9 |
| ROE % | -390.4 | 3.7 |
| Net Margin % | -16142.0 | 3.8 |
| Rev Growth 5Y % | -33.1 | 10.0 |
| D/E | 0.0 | 0.2 |
Precio Objetivo de Analistas
Hold
$11.75
+247.6%
Low: $10.00
High: $14.00
EPS Futuro
-$0.48
Ingresos Est.
470000
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$0.23
$0.23 – $0.23
|
440 M | 4 |
| FY2029 |
-$0.26
-$0.26 – -$0.26
|
190 M | 4 |
| FY2028 |
-$0.47
-$0.77 – -$0.29
|
20 M | 10 |
Puntos Clave
Revenue declined -33.07% annually over 5 years
Debt/Equity of 0.01 — conservative balance sheet
Negative free cash flow of -103.58M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 1260.67%
Crecimiento
Revenue Growth (5Y)
-33.07%
Revenue (1Y)1227.60%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-390.36%
ROIC-38.20%
Net Margin-16142.02%
Op. Margin-2789.46%
Seguridad
Debt / Equity
0.01
Current Ratio11.74
Interest Coverage-98.16
Valoración
P/E Ratio
-0.97
P/B Ratio2.87
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 1227.60% | Revenue Growth (3Y) | 260.86% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -33.07% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 4.09M | Net Income (TTM) | -660.05M |
| ROE | -390.36% | ROA | -212.55% |
| Gross Margin | 75.25% | Operating Margin | -2789.46% |
| Net Margin | -16142.02% | Free Cash Flow (TTM) | -103.58M |
| ROIC | -38.20% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.01 | Current Ratio | 11.74 |
| Interest Coverage | -98.16 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -0.97 | P/B Ratio | 2.87 |
| P/S Ratio | 155.92 | PEG Ratio | -0.01 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 637.55M | Enterprise Value | 554.32M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4.09M | 308,000.0 | 314,000.0 | 233,000.0 | 20.38M |
| Net Income | -660.05M | -149.27M | -40.22M | -152.39M | -167.81M |
| EPS (Diluted) | -2.91 | -0.93 | -0.25 | -0.91 | -0.83 |
| Gross Profit | 3.08M | 308,000.0 | 314,000.0 | 233,000.0 | 20.38M |
| Operating Income | -114.06M | -102.69M | -125.47M | -144.79M | -135.81M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 310.54M | 159.39M | 293.48M | 305.44M | 414.17M |
| Total Liabilities | 88.54M | 42.83M | 49.16M | 39.68M | 28.21M |
| Shareholders' Equity | 221.87M | 116.30M | 242.96M | 260.74M | 376.91M |
| Total Debt | 2.07M | 24.71M | 19.14M | 15.34M | 743,000.0 |
| Cash & Equivalents | 85.30M | 17.51M | 45.03M | 190.61M | 362.27M |
| Current Assets | 275.68M | 80.13M | 185.59M | 287.15M | 375.08M |
| Current Liabilities | 23.48M | 24.95M | 20.12M | 19.90M | 20.94M |